Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Clinical trial NCT05983445 · COMPLETED

Trial details

NCT number: NCT05983445
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Gout Arthritis

Start date: 2023-01-11
Primary completion: 2024-04-03
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.